Harmony Biosciences Holdings (HRMY) Goodwill & Intangibles (2019 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Goodwill & Intangibles came in at $215.0 million in Q1 2026, little changed year-on-year from $215.0 million in Q1 2025, and little changed quarter-over-quarter from $215.0 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Goodwill & Intangibles across 8 years of filings, most recently posting $215.0 million for Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $215.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $215.0 million (changed 0.0% YoY), and the FY2025 annual result was $215.0 million, changed 0.0% from the prior year.
- Goodwill & Intangibles came in at $215.0 million for Q1 2026 at Harmony Biosciences Holdings, roughly flat from $215.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $215.0 million in Q2 2022 to a low of $95.4 million in Q3 2025.
- The 5-year median for Goodwill & Intangibles is $215.0 million (2022), against an average of $190.7 million.
- Across the five-year window, Goodwill & Intangibles soared 49.39% in 2022 and sank 52.86% in 2025, its largest moves.
- Harmony Biosciences Holdings' Goodwill & Intangibles stood at $215.0 million in 2022, then changed by 0.0% to $215.0 million in 2023, then changed by 0.0% to $215.0 million in 2024, then changed by 0.0% to $215.0 million in 2025, then changed by 0.0% to $215.0 million in 2026.
- The last three Goodwill & Intangibles figures came in at $215.0 million (Q1 2026), $215.0 million (Q4 2025), and $95.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215.00 Mn |
| Dec 31, 2025 | 215.00 Mn |
| Sep 30, 2025 | 95.38 Mn |
| Jun 30, 2025 | 101.34 Mn |
| Mar 31, 2025 | 215.00 Mn |
| Dec 31, 2024 | 215.00 Mn |
| Sep 30, 2024 | 119.23 Mn |
| Jun 30, 2024 | 215.00 Mn |
| Mar 31, 2024 | 215.00 Mn |
| Dec 31, 2023 | 215.00 Mn |
| Sep 30, 2023 | 215.00 Mn |
| Jun 30, 2023 | 215.00 Mn |
| Mar 31, 2023 | 215.00 Mn |
| Dec 31, 2022 | 215.00 Mn |
| Sep 30, 2022 | 166.91 Mn |
| Jun 30, 2022 | 215.00 Mn |
| Mar 31, 2022 | 178.84 Mn |
| Dec 31, 2021 | 143.92 Mn |
| Sep 30, 2021 | 148.56 Mn |
| Jun 30, 2021 | 153.14 Mn |